ULORIC (Aphena Pharma Solutions – Tennessee, LLC)


Welcome to the PulseAid listing for the ULORIC drug offered from Aphena Pharma Solutions – Tennessee, LLC. This Xanthine Oxidase Inhibitor [EPC],Xanthine Oxidase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Aphena Pharma Solutions – Tennessee, LLC
NON-PROPRIETARY NAME: febuxostat
SUBSTANCE NAME: FEBUXOSTAT
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Xanthine Oxidase Inhibitor [EPC],Xanthine Oxidase Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2009-02-13
END MARKETING DATE: 0000-00-00


ULORIC HUMAN PRESCRIPTION DRUG Details:

Item DescriptionULORIC from Aphena Pharma Solutions – Tennessee, LLC
LABELER NAME: Aphena Pharma Solutions – Tennessee, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 40(mg/1)
START MARKETING DATE: 2009-02-13
END MARKETING DATE: 0000-00-00
PRODUCT ID: 43353-305_ffb92b61-2291-4a2c-850c-9e11a2b7037a
PRODUCT NDC: 43353-305
APPLICATION NUMBER: NDA021856

Other FEBUXOSTAT Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Aphena Pharma Solutions – Tennessee, LLCULORIC
Avera McKennan HospitalULORIC
Cardinal HealthULORIC
Ranbaxy Pharmaceuticals Inc.Febuxostat
Rebel Distributors CorpULORIC
Takeda Pharmaceuticals America, Inc.ULORIC